Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Sequential Vaccinations With ALVAC-CEA and Vaccinia-CEA With the Addition of IL-2 and GM-CSF in Patients With CEA Expressing Tumors

NCT00003125 is registered in ClinicalTrials.gov with Georgetown University as lead sponsor.

NCT NCT00003125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Sequential Vaccinations With ALVAC-CEA and Vaccinia-CEA With the Addition of IL-2 and GM-CSF in Patients With CEA Expressing Tumors
Lead sponsor
Georgetown University
Phase
Phase 2
Overall status
Completed
Start date
January 31, 1998
Completion date
November 30, 2004
Enrollment
24 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, esophageal cancer, gastric cancer, lung cancer, pancreatic cancer, unspecified adult solid tumor, protocol specific